drugset / Trial / NCT06554470
Local vs Systemic Methotrexate in Management of Uterine Ectopic Pregnancy
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to compare local and systemic methotrexate in the management of uterine ectopic pregnancy regarding the duration of beta human chorionic gonadotropin (hCG) clearance and need for further management options.
Timeline
- Start
- 2024-08-15
- Primary completion
- 2025-07-01
- Completion
- 2025-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methotrexate | Small molecule | 25 mg | Intramuscular |
| Subject | Methotrexate | Small molecule | 50 mg/m2 | Intramuscular |